The High Authority for Health considers that Prof. Even’s remarks are not responsible and that these statements may encourage patients to interrupt their treatment wrongly.
The event is rare enough to be reported. A few hours after the publication of the good sheets of Pr Philippe Even’s book indicating that there is “no bad cholesterol”, the High Authority for Health (Has) reacted vigorously. “Worrying the sick, provoking their distrust vis-à-vis a useful treatment and vis-à-vis the doctors who prescribe their treatment is not responsible,” said the press release. Running the risk of stopping their treatment for patients who really need it places a heavy responsibility on the author of this book ”.
La Has recalls that “after a cardiovascular accident, a heart attack or a stroke, the interest of statins is indisputable”. In primary prevention, that is to say before an accident, these molecules are justified for people at high risk, those who have cumulative risk factors, diabetes, HT or smoking.
In the case of an isolated and non-familial hypercholesterolemia, the prescription of statins proves ineffective, indicates the High Authority, which confirms a “misuse of statins in primary prevention”. On the other hand, she recommends that patients do not interrupt their treatment without first discussing it with their doctor.
Listen to Prof. Jean-Luc Harousseau, President of the Haute Autorité de santé: “There are two situations where the value of statins is not in doubt.”
Beyond this medical update, the health agency fears that the succession of cases which “have shaken the world of health” undermine the confidence of the French in the health system.
A few hours before, the pharmaceutical industry union (Leem) denounced “the irresponsibility of Professor Even with regard to patients”. and “staging for personal use. “
.
